close

Agreements

Date: 2016-04-04

Type of information: Nomination

Compound:

Company: Tiziana Life Sciences (UK)

Therapeutic area: Cancer - Oncology - Immunological diseases

Type agreement:

nomination

Action mechanism:

Disease:

Details:

* On April 4, 2016, Tiziana Life Sciences announced that it has appointed Tiziano Lazzaretti as Chief Financial Officer, effective immediately. Mr Lazzaretti’s appointment is not to the Company’s board of directors. Mr Lazzaretti has extensive experience in the healthcare and pharmaceutical industry and joins Tiziana from Pharmentis Srl, an Italian pharmaceutical business, where he served as Group Finance Director since 2011. Prior to this, Mr Lazzaretti held senior roles at Alliance Boots Healthcare, Accenture and other listed companies such as SNIA Spa and Fiat Group.
He has a Bachelor of Science (BSc hons) in Accounting and Finance from the University of Turin, Italy and was awarded a Master in Business Administration (MBA) from Bocconi University, Milan.

Financial terms:

Latest news:

Is general: Yes